↓ Skip to main content

Current management of parainfluenza pneumonitis in immunocompromised patients: a review

Overview of attention for article published in Infection and Drug Resistance, August 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
Published in
Infection and Drug Resistance, August 2012
DOI 10.2147/idr.s25874
Pubmed ID
Authors

Ann R Falsey

Abstract

Parainfluenza viruses (PIV) are common respiratory viruses that belong to the Paramyxoviridae family. PIV infection can lead to a wide variety of clinical syndromes ranging from mild upper respiratory illness to severe pneumonia. Severe disease can be seen in elderly or chronically ill persons and may be fatal in persons with compromised immune systems, particularly children with severe combined immunodeficiency disease syndrome and hematopathic stem cell transplant recipients. At present, there are no licensed antiviral agents for the treatment of PIV infection. Aerosolized or systemic ribavirin in combination with intravenous gamma globulin has been reported in small, uncontrolled series and case reports of immunocompromised patients. A number of agents show antiviral activity in vitro and in animals, but none are currently approved for human use.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
United Kingdom 1 2%
Unknown 47 94%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Researcher 6 12%
Student > Ph. D. Student 5 10%
Student > Doctoral Student 4 8%
Professor > Associate Professor 4 8%
Other 12 24%
Unknown 13 26%
Readers by discipline Count As %
Medicine and Dentistry 18 36%
Agricultural and Biological Sciences 6 12%
Biochemistry, Genetics and Molecular Biology 5 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Computer Science 2 4%
Other 5 10%
Unknown 12 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2012.
All research outputs
#20,823,121
of 25,584,565 outputs
Outputs from Infection and Drug Resistance
#1,293
of 2,048 outputs
Outputs of similar age
#140,428
of 179,468 outputs
Outputs of similar age from Infection and Drug Resistance
#3
of 3 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,048 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,468 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.